How common is airflow limitation in patients with emphysema on CT scan of the chest?

Chest

Volumn 148, Issue 1, 2015, Pages 176-184

  Lutchmedial, Sanjiva M ^a   Creed, Whitney G ^a   Moore, Alastair J ^b   Walsh, Ryan R ^c   Gentchos, George E ^c   Kaminsky, David A ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b Department of Radiology ^*  (United States)

^c Fletcher Allen Health Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AIRWAY OBSTRUCTION; AMERICAN THORACIC SOCIETY EUROPEAN RESPIRATORY SOCIETY CRITERIA LOWER LIMIT OF NORMAL; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBESITY; PATIENT IDENTIFICATION; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; RESPIRATORY TRACT DISEASE ASSESSMENT; RETROSPECTIVE STUDY; SPIROMETRY; THORAX; AIRWAY RESISTANCE; COMPLICATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PULMONARY EMPHYSEMA; RADIOGRAPHY; RISK FACTOR; VITAL CAPACITY;

AGED; AIRWAY RESISTANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; PREVALENCE; PULMONARY EMPHYSEMA; RETROSPECTIVE STUDIES; RISK FACTORS; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY;

EID: 84937598187     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-1556     Document Type: Article

References (45)

1. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364(9435):709-721.
2. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care. 2001;46(8):798-825.
3. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-365.
4. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-968.
5. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000; 160(11):1683-1689.
6. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):721-732.
7. Bafadhel M, Umar I, Gupta S, et al. The role of CT scanning in multidimensional phenotyping of COPD. Chest. 2011;140(3):634-642.
8. Patel BD, Coxson HO, Pillai SG, et al; International COPD Genetics Network . Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178(5): 500-505.
9. Bergin C, Müller N, Nichols DM, et al. The diagnosis of emphysema. A computed tomographic-pathologic correlation. Am Rev Respir Dis. 1986;133(4):541-546.
10. Schroeder JD, McKenzie AS, Zach JA, et al. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. AJR Am J Roentgenol. 2013;201(3):W460-W470.
11. Dijkstra AE, Postma DS, ten Hacken N, et al. Low-dose CT measurements of airway dimensions and emphysema associated with airflow limitation in heavy smokers: a cross sectional study. Respir Res. 2013;14:11.
12. Nishimura M, Makita H, Nagai K, et al Hokkaido COPD Cohort Study Investigators. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(1):44-52.
13. Johannessen A, Skorge TD, Bottai M, et al. Mortality by level of emphysema and airway wall thickness. Am J Respir Crit Care Med. 2013;187(6):602-608.
14. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182(5):598-604.
15. Martinez CH, Chen YH, Westgate PM, et al COPDGene Investigators. Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax. 2012;67(5):399-406.
16. Miller MR, Hankinson J, Brusasco V, et al ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338.
17. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179-187.
18. Coxson HO, Mayo J, Lam S, Santyr G, Parraga G, Sin DD. New and current clinical imaging techniques to study chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(7):588-597.
19. Diaz AA, Bartholmai B, San José Estépar R, et al. Relationship of emphysema and airway disease assessed by CT to exercise capacity in COPD. Respir Med. 2010; 104(8):1145-1151.
20. Gietema HA, Müller NL, Fauerbach PV, et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. Acad Radiol. 2011;18(6):661-671.
21. Wan ES, Hokanson JE, Murphy JR, et al COPDGene Investigators. Clinical and radiographic predictors of GOLDunclassified smokers in the COPDGene study. Am J Respir Crit Care Med. 2011;184(1):57-63.
22. Wang Z, Gu S, Leader JK, et al. Optimal threshold in CT quantification of emphysema. Eur Radiol. 2013;23(4):975-984.
23. Bhatt SP, Sieren JC, Dransfield MT, et al COPDGene Investigators. Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax. 2014;69(5):409-414.
24. Lee YK, Oh YM, Lee JH, et al KOLD Study Group. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung. 2008;186(3):157-165.
25. Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. Chest. 2007;131(2):349-355.
26. Güder G, Brenner S, Angermann CE, et al. GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respir Res. 2012;13(1):13.
27. Jones RL, Nzekwu MM. The effects of body mass index on lung volumes. Chest. 2006;130(3):827-833.
28. O'Donnell DE, Deesomchok A, Lam YM, et al. Effects of BMI on static lung volumes in patients with airway obstruction. Chest. 2011;140(2):461-468.
29. Ogawa E, Nakano Y, Ohara T, et al. Body mass index in male patients with COPD: correlation with low attenuation areas on CT. Thorax. 2009;64(1):20-25.
30. Makita H, Nasuhara Y, Nagai K, et al Hokkaido COPD Cohort Study Group. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax. 2007;62(11):932-937.
31. Hasegawa M, Nasuhara Y, Onodera Y, et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006; 173(12):1309-1315.
32. Kim SS, Seo JB, Lee HY, et al. Chronic obstructive pulmonary disease: lobe-based visual assessment of volumetric CT by using standard images-comparison with quantitative CT and pulmonary function test in the COPDGene study. Radiology. 2013;266(2):626-635.
33. Mair G, Maclay J, Miller JJ, et al. Airway dimensions in COPD: relationships with clinical variables. Respir Med. 2010; 104(11):1683-1690.
34. Holme J, Stockley RA. Radiologic and clinical features of COPD patients with discordant pulmonary physiology: lessons from alpha1-antitrypsin deficiency. Chest. 2007;132(3):909-915.
35. Mair G, Miller JJ, McAllister D, et al. Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers. Eur Respir J. 2009;33(3):536-542.
36. Thomas M, Decramer M, O'Donnell DE. No room to breathe: the importance of lung hyperinflation in COPD. Prim Care Respir J. 2013;22(1):101-111.
37. Grydeland TB, Thorsen E, Dirksen A, et al. Quantitative CT measures of emphysema and airway wall thickness are related to D(L)CO. Respir Med. 2011;105(3):343-351.
38. Gietema HA, Zanen P, Schilham A, et al. Distribution of emphysema in heavy smokers: impact on pulmonary function. Respir Med. 2010;104(1):76-82.
39. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med. 2000;162(3 pt 1):1102-1108.
40. Mets OM, Murphy K, Zanen P, et al. The relationship between lung function impairment and quantitative computed tomography in chronic obstructive pulmonary disease. Eur Radiol. 2012;22(1):120-128.
41. Hesselbacher SE, Ross R, Schabath MB, et al. Cross-sectional analysis of the utility of pulmonary function tests in predicting emphysema in ever-smokers. Int J Environ Res Public Health. 2011;8(5):1324-1340.
42. Friedman PJ. Imaging studies in emphysema. Proc Am Thorac Soc. 2008;5(4): 494-500.
43. Betsuyaku T, Yoshioka A, Nishimura M, Miyamoto K, Kawakami Y. Pulmonary function is diminished in older asymptomatic smokers and ex-smokers with low attenuation areas on highresolution computed tomography. Respiration. 1996;63(6):333-338.
44. Hochhegger B, Alves GR, Irion KL, Moreira JdaS, Marchiori EdosS. Emphysema index in a cohort of patients with no recognizable lung disease: influence of age. J Bras Pneumol. 2012;38(4):494-502.
45. Dyer C. The interaction of ageing and lung disease. Chron Respir Dis. 2012;9(1):63-67.